ADC Therapeutics SA Quarterly Assets in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: ADC Therapeutics SA quarterly Assets history and growth rate from Q4 2022 to Q3 2024.
ADC Therapeutics SA Assets for the quarter ending September 30, 2024 was $349M, a 25.2% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$349M	-$118M	-25.2%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$372M	-$136M	-26.7%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$308M	-$160M	-34.1%	Mar 31, 2024	10-Q	2024-05-06
Q4 2023	$355M	-$136M	-27.7%	Dec 31, 2023	10-Q	2024-11-07
Q4 2022	$491M	-$127M	-20.6%	Dec 31, 2022	10-K	2024-03-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.